These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36614172)

  • 1. The Association of Glucose Control with Circulating Levels of Red Blood Cell-Derived Vesicles in Type 2 Diabetes Mellitus Patients with Atrial Fibrillation.
    Berezin AA; Obradovic Z; Kopp K; Berezina TA; Lichtenauer M; Wernly B; Berezin AE
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant increase of serum extracellular vesicle-packaged growth differentiation factor 15 in type 2 diabetes mellitus: a cross-sectional study.
    Zhao W; Li X; Li X; Peng L; Li Y; Du Y; He J; Qin Y; Zhang H
    Eur J Med Res; 2023 Jan; 28(1):37. PubMed ID: 36658625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of shorter red blood cell lifespan on the rate of HbA1c target achieved in type 2 diabetes patients with a HbA1c detection value lower than 7.
    Wang J; Zhang L; Bai Y; Wang X; Wang W; Li J; Zhou S
    J Diabetes; 2023 Jan; 15(1):7-14. PubMed ID: 36541364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clearance and phenotype of extracellular vesicles after red blood cell transfusion in a human endotoxemia model.
    van Manen L; Peters AL; van der Sluijs PM; Nieuwland R; van Bruggen R; Juffermans NP
    Transfus Apher Sci; 2019 Aug; 58(4):508-511. PubMed ID: 31253560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Effects of Bariatric Surgery on the Incidence of Heart Failure and Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus and Obesity and on Mortality in Patients With Preexisting Heart Failure: A Nationwide, Matched, Observational Cohort Study.
    Höskuldsdóttir G; Sattar N; Miftaraj M; Näslund I; Ottosson J; Franzén S; Svensson AM; Eliasson B
    J Am Heart Assoc; 2021 Apr; 10(7):e019323. PubMed ID: 33754795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of diabetes mellitus in patients with atrial fibrillation.
    Papazoglou AS; Kartas A; Samaras A; Vouloagkas I; Vrana E; Moysidis DV; Akrivos E; Kotzampasis G; Baroutidou A; Papanastasiou A; Liampas E; Botis M; Karagiannidis E; Stalikas N; Karvounis H; Tzikas A; Giannakoulas G
    Cardiovasc Diabetol; 2021 Feb; 20(1):40. PubMed ID: 33573666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher long-term visit-to-visit glycemic variability predicts new-onset atrial fibrillation in patients with diabetes mellitus.
    Hsu JC; Yang YY; Chuang SL; Yu CC; Lin LY
    Cardiovasc Diabetol; 2021 Jul; 20(1):148. PubMed ID: 34301257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular vesicles in atrial fibrillation and stroke.
    Thulin Å; Lindbäck J; Granger CB; Wallentin L; Lind L; Siegbahn A
    Thromb Res; 2020 Sep; 193():180-189. PubMed ID: 32717643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation.
    Shaihov-Teper O; Ram E; Ballan N; Brzezinski RY; Naftali-Shani N; Masoud R; Ziv T; Lewis N; Schary Y; Levin-Kotler LP; Volvovitch D; Zuroff EM; Amunts S; Regev-Rudzki N; Sternik L; Raanani E; Gepstein L; Leor J
    Circulation; 2021 Jun; 143(25):2475-2493. PubMed ID: 33793321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced deformability of stored red blood cells is associated with generation of extracellular vesicles.
    McVey MJ; Kuebler WM; Orbach A; Arbell D; Zelig O; Barshtein G; Yedgar S
    Transfus Apher Sci; 2020 Oct; 59(5):102851. PubMed ID: 32571640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between glycated haemoglobin concentration and erythrocyte survival in type 2 diabetes mellitus determined by a modified carbon monoxide breath test.
    Huang Z; Liu Y; Mao Y; Chen W; Xiao Z; Yu Y
    J Breath Res; 2018 Jan; 12(2):026004. PubMed ID: 28972196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.
    Zelniker TA; Bonaca MP; Furtado RHM; Mosenzon O; Kuder JF; Murphy SA; Bhatt DL; Leiter LA; McGuire DK; Wilding JPH; Budaj A; Kiss RG; Padilla F; Gause-Nilsson I; Langkilde AM; Raz I; Sabatine MS; Wiviott SD
    Circulation; 2020 Apr; 141(15):1227-1234. PubMed ID: 31983236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated blood plasma levels of tissue factor-bearing extracellular vesicles in patients with atrial fibrillation.
    Mørk M; Andreasen JJ; Rasmussen LH; Lip GYH; Pedersen S; Bæk R; Jørgensen MM; Kristensen SR
    Thromb Res; 2019 Jan; 173():141-150. PubMed ID: 30530119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of long-term glycemic variability on development of atrial fibrillation in type 2 diabetic patients.
    Gu J; Fan YQ; Zhang JF; Wang CQ
    Anatol J Cardiol; 2017 Dec; 18(6):410-416. PubMed ID: 29256876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.
    Fangel MV; Nielsen PB; Kristensen JK; Larsen TB; Overvad TF; Lip GYH; Jensen MB
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007030. PubMed ID: 30995869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c.
    Cohen RM; Franco RS; Khera PK; Smith EP; Lindsell CJ; Ciraolo PJ; Palascak MB; Joiner CH
    Blood; 2008 Nov; 112(10):4284-91. PubMed ID: 18694998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of heart-rate recovery to new onset heart failure and atrial fibrillation in patients with diabetes mellitus and preserved ejection fraction.
    Negishi K; Seicean S; Negishi T; Yingchoncharoen T; Aljaroudi W; Marwick TH
    Am J Cardiol; 2013 Mar; 111(5):748-53. PubMed ID: 23273718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SGLT2 inhibitors and atrial fibrillation in type 2 diabetes: a systematic review with meta-analysis of 16 randomized controlled trials.
    Li WJ; Chen XQ; Xu LL; Li YQ; Luo BH
    Cardiovasc Diabetol; 2020 Aug; 19(1):130. PubMed ID: 32847602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shock-Driven Endotheliopathy in Trauma Patients Is Associated with Leucocyte Derived Extracellular Vesicles.
    Dujardin RWG; Kisters JEC; Wirtz MR; Hajji N; Tuip-de Boer AM; Stensballe J; Johansson PI; Brohi K; Davenport RA; Gaarder C; Stanworth S; Maegele M; Nieuwland R; van der Pol E; Juffermans NP
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation.
    Polovina M; Lund LH; Đikić D; Petrović-Đorđević I; Krljanac G; Milinković I; Veljić I; Piepoli MF; Rosano GMC; Ristić AD; Ašanin M; Seferović PM
    Eur J Heart Fail; 2020 Jan; 22(1):113-125. PubMed ID: 31822042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.